EP 1531867 A1 20050525 - METASTABLE PHARMACEUTICAL COMPOSITIONS
Title (en)
METASTABLE PHARMACEUTICAL COMPOSITIONS
Title (de)
METASTABILE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES METASTABLES
Publication
Application
Priority
- AU 0300785 W 20030624
- AU PS317302 A 20020625
Abstract (en)
[origin: WO2004000361A1] The present invention provides a pharmaceutical composition for transdermal delivery comprising; one or more physiologically active agents; and a volatile pharmaceutically acceptable solvent; and wherein the physiological active agent forms a metastable deposit upon evaporation of the volatile solvent.
IPC 1-7
A61K 47/10; A61K 9/06; A61K 31/568; A61K 31/565; A61K 31/435; A61K 31/496; A61P 15/10; A61P 15/18; A61P 25/04; A61P 25/22
IPC 8 full level
A61K 9/12 (2006.01); A61K 9/70 (2006.01); A61K 31/137 (2006.01); A61K 31/165 (2006.01); A61K 31/216 (2006.01); A61K 31/4025 (2006.01); A61K 31/4045 (2006.01); A61K 31/4196 (2006.01); A61K 31/435 (2006.01); A61K 31/4468 (2006.01); A61K 31/473 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/565 (2006.01); A61K 31/567 (2006.01); A61K 31/568 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61M 11/00 (2006.01); A61P 5/24 (2006.01); A61P 13/10 (2006.01); A61P 15/10 (2006.01); A61P 15/18 (2006.01); A61P 25/02 (2006.01); A61P 25/04 (2006.01); A61P 25/06 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 29/00 (2006.01); A61P 29/02 (2006.01)
CPC (source: EP KR)
A61K 9/0014 (2013.01 - EP); A61K 9/06 (2013.01 - KR); A61K 9/7015 (2013.01 - EP); A61K 31/435 (2013.01 - EP); A61K 31/496 (2013.01 - EP); A61K 31/565 (2013.01 - EP KR); A61K 31/567 (2013.01 - EP); A61K 31/568 (2013.01 - EP KR); A61K 47/10 (2013.01 - EP KR); A61K 47/32 (2013.01 - EP); A61K 47/38 (2013.01 - EP); A61P 5/24 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 29/02 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004000361 A1 20031231; AU PS317302 A0 20020718; BR 0312003 A 20050322; CA 2490057 A1 20031231; EA 012648 B1 20091230; EA 200500083 A1 20050825; EP 1531867 A1 20050525; EP 1531867 A4 20110323; JP 2005534670 A 20051117; JP 2010248250 A 20101104; KR 20050120726 A 20051223; NZ 537436 A 20070126
DOCDB simple family (application)
AU 0300785 W 20030624; AU PS317302 A 20020625; BR 0312003 A 20030624; CA 2490057 A 20030624; EA 200500083 A 20030624; EP 03729714 A 20030624; JP 2004514438 A 20030624; JP 2010172167 A 20100730; KR 20047020966 A 20041223; NZ 53743603 A 20030624